학술논문
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial
Document Type
Article
Author
Tricou, V.; Rauscher, M.; Zent, O.; Folschweiller, N.; LeFevre, I.; Yu, D.; Reynales, H.; Biswal, S.; Escudero, I.; Lloyd, E.; Wallace, D.; Saez-Llorens, X.; Sirivichayakul, C.; Lopez, P.; Borja-Tabora, C.; Bravo, L.; Kosalaraksa, P.; Vargas, L.M.; Alera, M.T.; Rivera, L.; Watanaveeradej, V.; Dietze, R.; Fernando, L.; Wickramasinghe, V.P.; Moreira, E.D.; Fernando, A.D.; Gunasekera, D.; Luz, K.; Oliveira, A.L.; Tuboi, S.; Hutagalung, Y.; Espinoza, F.
Source
In: The Lancet Global Health . (The Lancet Global Health, February 2024, 12(2):e257-e270)
Subject
Language
English
ISSN
2214109X